Extra-pleural pneumonectomy in the setting of tri-modality therapy for patients with malignant pleur

• 作 者: Alexander Chi Sijin Wen Nam P. Nguyen Geraldine Jacobson Scot Remick William Tse Zhongxing Liao
• 机 构: Department of Radiation Oncology, West Virginia University,Department of Biostatistics, West Virgini
• 出 处: Chinese Journal of Cancer Research
• 发表日期: 2013年02期
• 关键词: pleural modality malignancy thoracic radiotherapy mortality chemotherapy accepta

Although declining in the US due to restrictions of asbestos exposure, malignant pleural mesothelioma (MPP) remains a very serious thoracic malignancy that is rising in incidence worldwide (1). Trimodality therapy with chemotherapy and radiotherapy combined with extrapleural pneumonectomy (EPP) has gained acceptance given the acceptable mortality

Although declining in the US due to restrictions of asbestos exposure, malignant pleural mesothelioma (MPP) remains a very serious thoracic malignancy that is rising in incidence worldwide (1). Trimodality therapy with chemotherapy and radiotherapy combined with extrapleural pneumonectomy (EPP) has been added acceptance given the acceptable mortality